International Biotechnology Trust’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

International Biotechnology Trust’s Portfolio ARIA Stock Details ARIA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-657,912	Closed	-$8.18M	–	65
2016 Q4	$8.18M	Buy	+657,912	New	+$7.92M	3.69%	9

Other funds holding ARIA

FPF

FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return

International Biotechnology Trust's ARIA Position: Q1 2017 in Review

International Biotechnology Trust sold out of Ariad Pharmaceuticals Inc (ARIA) in Q1 2017, closing a stake of 657,912 shares — an estimated $8.18M sold.

International Biotechnology Trust first reported a position in ARIA in Q4 2016 and held it in 1 quarter. The position peaked at $8.18M in Q4 2016. 1 fund tracked by Wall St. Rank holds ARIA as of Q1 2017.

International Biotechnology Trust reported no remaining Ariad Pharmaceuticals Inc position as of Q1 2017 after selling out during the quarter.
International Biotechnology Trust sold 657,912 Ariad Pharmaceuticals Inc shares in Q1 2017, an estimated $8.18M.
International Biotechnology Trust first reported a position in Ariad Pharmaceuticals Inc in Q4 2016 and held it in 1 quarter.
International Biotechnology Trust's Ariad Pharmaceuticals Inc position peaked at $8.18M in Q4 2016.
1 fund tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q1 2017.

Based on International Biotechnology Trust's 13F filing for Q1 2017, filed 2 Mar 2018.